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ABSTRACT
Impaired glucose tolerance is the key defining characteristic of diabetes, a condition
which affects nearly 30% of Americans2. Hydration status and the physiological effects
of poor hydration have been linked to compromised glucose tolerance in animal models,
but has not been thoroughly investigated in humans.
PURPOSE: The purpose of this investigation was to observe the effect of altered
hydration status on a healthy male adult’s response to an oral glucose tolerance test
(OGTT). METHODS: Four healthy adult men (28.4±1 y, 23.6±1.2 kg/m2, HbA1C
5.6±0.2%, non-smoking, non-athletes) participated. Subjects took OGTT’s in both a
hypohydrated and euhydrated state. The euhydrated state was achieved by infusing an
isotonic solution of 0.9% NaCl at a rate of 0.1 mL/min/kg for 120 minutes via venous
catheter, while the hypohydrated state was achieved by infusing a hypertonic solution of
3% NaCl at the same rate. Blood samples of 15 mL each were taken before infusion and
every 30 minutes during infusion. The OGTT commenced after 120 minutes of infusion
and blood samples were taken after 5, 30, 60, 90, and 120 minutes. RESULTS: Plasma
osmolality increased during the hypertonic infusion (to maximum 300 mmol/kg) and
remained normal during the isotonic infusion (284-288 mmol/kg). Plasma volume
increased during infusion in both conditions, though more significantly in the hypertonic
condition (maximum 16.5% increase from baseline) than in the isotonic condition
(maximum 5.6% increase from baseline). Both insulin and glycemic responses to the
OGTT showed a greater increase in the hypertonic condition (insulin peak 56.0 µU/mL;
glucose peak 138 mg/dL) than in the isotonic condition (insulin peak 41.7 µU/mL;
glucose peak 133 mg/dL). Three measures of insulin response–homeostatic model
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assessment for insulin resistance (HOMA IR), Matsuda index for insulin sensitivity, and
quantitative insulin sensitivity check index (QUICKI)–indicated decreased insulin
sensitivity and increased insulin resistance in the hypertonic condition (HOMA IR 0.93;
Matsuda 12.4; QUICKI 0.8) compared to the isotonic condition (HOMA IR 0.85;
Matsuda 12.67; QUICKI 0.9). However, none of the measured results reached the
thresholds for diagnosis of diabetes. CONCLUSION: Infusion of hypertonic saline
solution is a valid means of simulating hypohydration. Acute hypertonicity elicits an
acute, negative effect on glucose tolerance and insulin sensitivity in healthy men. Though
these results were only measured in an acute sense, there may be implications that
chronic proper hydration could be an effective and inexpensive means of delaying or
preventing the onset of type II diabetes in those with a high risk of developing the
condition.
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INTRODUCTION
Diabetes is the seventh leading cause of death among Americans, and as of 2012
nearly 3 million Americans had diabetes, with an additional 86 million adults showing
symptoms of prediabetes2. The prevalence of diabetes in the United States cost
approximately $245 billion in 20122. Inadequate glucose regulation due to insulin
resistance is the defining characteristic of type II diabetes mellitus (T2DM). In a healthy
adult, fasting plasma glucose concentration is typically less than 100 mg/dL, and 2 hours
after an oral glucose tolerance test (OGTT) is less than 140 mg/dL1. Diabetes is
diagnosed when one’s fasting plasma glucose concentration is greater than 126 mg/dL
and is over 200 mg/dL after an OGTT or at any given time1. Untreated hyperglycemia
can have several damaging effects on the body, including cardiovascular disease,
neuropathy, nephropathy, problems with the eyes, poor blood circulation, and infection6.
In a healthy, euhydrated condition, glucose levels are expected to rise
immediately following ingestion of high amounts of carbohydrates, but due to the
regulatory effects of the hormones glucagon and insulin, plasma glucose levels should
fall over time. Therefore, a higher concentration of glucose in the blood, or one that takes
longer to subside after ingestion is an indication of poor glucose tolerance. Insulin is
released into the bloodstream in response in increased plasma glucose concentrations and
binds to cells allowing glucose to enter them from the bloodstream, thereby reducing the
amount of glucose in the blood5. In cases of T2DM, this process is altered and the body is
unable to properly regulate the blood’s glucose concentration, leading to hyperglycemia5.
The efficacy of insulin has been directly linked to hydration status, though the
mechanisms and extent of this relationship have not been adequately investigated11.
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Hydration status has been found to effect glucose tolerance both in animals and in
humans 7, 10. Poor hydration increases the risk of hyperglycemia and leads to
compromised plasma glucose regulation in healthy adults7 and in those already diagnosed
with T2DM3. In diabetics, dehydration leads to increases in plasma glucose by reducing
the amount of insulin, triggering gluconeogenesis, and increasing the amount of
glucagon, a hormone with the opposite effect of insulin3. In camels, dehydration has been
found to alter the response to glucose loading, causing plasma glucose to increase more
and stay elevated longer when in a dehydrated state than when the same amount of
glucose is introduced to a euhydrated individual10.
Vasopressin, also known as antidiuretic hormone (ADH), is released in response
to an increase in plasma osmolality and acts to increase water retention by the kidneys.
Vasopressin has also been linked to glucose tolerance, with studies observing that a
chronic increase in vasopressin can lead to decreased glucose tolerance and even
hyperglycemia8. High levels of copeptin, a marker of vasopressin, contribute to insulin
resistance and can be used to predict the risk of developing T2DM4. In this investigation,
vasopressin was not measured, because it is well known and confirmed by many studies
that the hormone is released due to increases in plasma osmolality9. We can infer that any
results of this study may be related to a rise in vasopressin, or any other effect of
dehydration.
The purpose of this investigation was to observe the effects of increased plasma
hypertonicity and vasopressin on glucose tolerance in healthy adults. In the first phase of
the study, hypertonic saline infusion was used to increase the osmotic concentration of
the blood, simulating dehydration. During this period, plasma volume and blood
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osmolality were measured periodically. The second phase consisted of an OGTT after 2
hours of hypertonic saline infusion in order to measure various components of glucose
tolerance, including plasma glucose concentration and insulin levels. The OGTT involves
subjects drinking a highly concentrated glucose drink and subsequent blood draws to
monitor glucose tolerance. OGTT results are commonly used in the diagnosis of T2DM
and prediabetes1. In this investigation, data regarding glucose tolerance was compared
between subjects after dehydration by hypertonic saline infusion and after a control
condition using isotonic saline infusion.
Glucose tolerance was measured by plasma insulin concentration, plasma glucose
concentration, and three measures of insulin tolerance. The homeostatic model
assessment for insulin resistance (HOMA IR) measures resting insulin resistance. The
Matsuda index measures whole body insulin sensitivity, the inverse of insulin resistance,
during an OGTT. The quantitative insulin sensitivity check index (QUICKI) measures
hepatic insulin sensitivity.

METHOD
Institutional Review Board (IRB) approval was given from the University of
Arkansas IRB (project IRB#: 14-12-360). The subjects for this investigation were four
healthy adult males ages 18 to 45 who demonstrated sedentary lifestyles. Exclusion
criteria for the subjects included obesity, diabetes, liver or kidney disease, cardiovascular
disease, recent operations, smoking, insulin therapy, and drastic weight change. Each
subject’s fluid and food intake were regulated 12 hours before the beginning of the
experiment. Participants were given a standardized dinner and 45mL/kg of water to

9
consume 12 hours prior to their arrival, and they were asked to refrain from caffeine,
alcohol, and exercise in the 24 hours prior to each visit. Subjects were asked to consume
a high-carbohydrate diet for the three days leading up to the study in order to reduce the
body’s glucose production due to low levels of dietary carbohydrates.
Each subject visited the Human Performance Laboratory three separate times over
the course of at least two weeks. The first visit was a screening visit to determine the
subject’s eligibility and ability to complete the study. Also during the screening visit,
body composition, body weight, and glycated hemoglobin (HbA1C) were measured.
HbA1C measures average blood glucose over the previous 2-3 months. Subjects’ HbA1C
had to be less than 5.7%, the standard for diagnosing prediabetes1. The following two
visits were experimental days during which each subject experienced one euhydrated
condition and one hypertonic condition. The two experimental days were separated by at
least one week but no more than four weeks.
Upon arrival, subjects were euhydrated and fasted. Urine samples and body
weights were used to confirm hydration status, then the subjects rested for a 30 minute
equilibration period before two venous catheters were inserted into the antecubital veins.
One catheter was used for periodic blood draws, while the other was for the infusion of
saline solution. The infusion solution was 3% NaCl for the hypertonic condition and
0.9% NaCl for the isotonic condition, and was administered at a rate of 0.1 mL/min/kg
for 120 minutes. Blood samples of 15 mL each were drawn from the catheter before the
infusion and at +30, + 60, +90, and +120 minutes from the start of the infusion. At the
end of the infusion period, the subject provided a second urine sample and was allowed to
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equilibrate for another 30 minute period, at the end of which another 15 mL blood sample
was drawn.
After the equilibration period the OGTT commenced with the subject drinking a
standardized glucose drink containing 75 g of glucose. The purpose of the OGTT is to
stimulate insulin and glucose responses following regulated consumption of dietary
carbohydrates. The subject sat at rest for the next 2 hours, and blood draws of 15 mL
each were taken at +5, +30, +60, +90, and +120 minutes from the start of the OGTT.

Time (min)

-180

-150

Rest

Begin
Infusion

Blood
sample

X

-120

X

-90

X

-60

X

-30

0

Rest

Begin
OGTT

X

5 30

60

90

120

X X

X

X

X

Table 1. Protocol and periodic blood draws
Each of the blood samples was analyzed for hemoglobin and hematocrit
immediately following extraction to measure plasma volume shift. The remaining blood
was centrifuged to yield plasma, which was analyzed for plasma osmolality by freezing
point depression. Additionally, glucose and insulin were measured by colorimetric assay
and radioimmunoassay, respectively, by Quest Diagnostics, a commercial laboratory.

RESULTS
Four healthy, non-smoking males aged 28.4±1 years were observed in this study.
Their BMI was 23.6±1.2 kg/m2, which is widely considered a healthy range. HbA1C for
the subjects was 5.6±0.2%, which falls in the normal range, according the the American
Diabetes Association1.
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During the first phase of the protocol, the hypertonic or isotonic saline infusion,
plasma osmolality and plasma volume were recorded with each blood draw. Plasma
volume is calculated by measuring the shift in hematocrit (hct), which indicates the
proportion of red blood cells. These data were measured throughout the rest period and
the second phase as well. The results indicate that plasma osmolality increases
significantly in the hypertonic condition and remains higher even up to 2 hours after the
infusion has stopped. The increase in plasma osmolality is well known to lead to an
increase in vasopressin, among other effects. Plasma volume increased slightly in the
isotonic condition during saline infusion but more significantly increased in the
hypertonic condition.

Osmolality
(mmol/kg)

Time
(min)
0.9%
NaCl
3%
NaCl

-150

-120

-90

-60

-30

0

284

286

286

286

286

284

290

293

298

300

5

30

60

90

120

286

287 288

288

287

287

300

299 300

299

298

297

Table 2. Average plasma osmolality

Plasma Osmolality
305
300
mmol/kg

295
290
285
280

-150

-120

-90

-60

-30

0

30

60

Time (min)
0.9% NaCl

3% NaCl

Figure 1. Average Plasma Osmolality
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Plasma
Volume
Shift (%
baseline)

Time
(min)
0.9%
NaCl
3%
NaCl

-150

-120

-90

-60

-30

0

5

30

60

90

120

0

2.7

5.6

2.0

2.8

-1.8

0.1

-0.8

1.0

3.8

2.6

0

7.3

13.6

16.0

16.5

12.6

12.1

10.2

9.8

8.5

9.0

Table 3. Average Plasma Volume

Plasma Volume
20
PV Shift (% baseline)

15
10

-150

-120

-90

-60

5
0

-30

0
-5
Time (min)

0.9% NaCl

30

60

90

120

3% NaCl

Figure 2. Average plasma volume
In the second phase of study the OGTT commenced at time t=0, and insulin and
glucose concentrations were measured with each subsequent blood draw. Both the insulin
and glycemic responses show the form of a typical response. After consumption of large
amounts of carbohydrates, plasma glucose is expected to rise for a period of time, then
return to the fasting state, with insulin levels following a similar curve in response to the
increased glycaemia. The results of this investigation indicate an increased rise in both
insulin and glycaemia in the hypertonic condition compared the the isotonic condition.
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Time (min) -150 -30
0
5
30
60
90 120
Insulin 0.9% NaCl
4.4 3.6 3.7 12.0 36.5 41.7 26.4 27.9
µU/mL 3% NaCl
5.0 3.2 4.2 8.6 33.4 56.0 34.2 26.1
Table 4. Insulin response to OGTT

Serum Insulin ( μU/mL)

Insulin Response to Glucose
80
60
40
20
0
-150

-120

-90

-60

-30

0

30

60

90

120

60

90 120

Time (min)
0.9% NaCl

3% NaCl

Figure 3. Insulin response to OGTT

Time
Glucose 0.9% NaCl
mg/dL 3.0% NaCl

-150 -120 -90 -60 -30
87
89

87
87

88
88

88
87

0

5

30

88 90 90 128 133 120 112
90 89 95 127 138 115 106

Table 5. Glycemic responses
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Glycemic Responses
Glucose (mg/dL)

180
160
140
120
100
80
60
-150

-120

-90

-60

-30

0

30

60

90

120

Time (min)
0.9% NaCl

3.0% NaCl

Figure 4. Glycemic responses
Utilizing the insulin and glucose concentrations, HOMA IR, Matsuda, and
QUICKI indices were calculated. Matsuda, and QUICKI, which indicate insulin
sensitivity, were greater in the isotonic condition. HOMA IR measures insulin resistance
and indicated the opposite results, since resistance is the inverse of sensitivity. These
findings suggest that the subjects were more sensitive to insulin when euhydrated than
when dehydrated.

0.9% NaCl
3% NaCl

HOMA IR
0.85
0.93

Matsuda
12.67
12.4

QUICKI
0.9
0.8

Table 6. Measures of insulin resistance and sensitivity
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HOMA IR = (fasting glucose × fasting insulin) / 405
Matsuda = 10,000 / √(fasting glucose × fasting insulin) × (mean OGTT
glucose × mean OGTT insulin)
QUICKI = 1 / [log(fasting insulin) + log(fasting glucose)]
Table 7. Calculating measures of insulin resistance and sensitivity

HOMA IR
0.94
0.92
0.90
0.88
0.86
0.84
0.82
0.80
0.9% NaCl

3.0% NaCl

Figure 5. Homeostatic model assessment for insulin resistance

MATSUDA
12.7
12.6
12.5
12.4
12.3
12.2
0.9% NaCl

3.0% NaCl

Figure 6. Matsuda measure of insulin sensitivity
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QUICKI
0.90
0.85
0.80
0.75
0.70
0.9% NaCl

3.0% NaCl

Figure 7. Quantitative insulin sensitivity check index
DISCUSSION
The goal of this investigation was to observe differences related to the infusion of
isotonic and hypertonic saline solutions and their potential effects on glucose tolerance.
The preliminary findings validated the practice of saline infusion as a method to simulate
dehydration and found that dehydration negatively effects glucose tolerance. The
hypertonic infusion led to an increase in plasma osmolality, due to the increase of solutes
entering the bloodstream during the infusion. This in turn caused an increase in plasma
volume as water diffused into the bloodstream from nearby cells in an effort to maintain
blood osmotic homeostasis.
Preliminary studies have suggested a correlation between poor hydration and
compromised glucose tolerance, which the present investigation supports3, 4, 7, 8. The
prolonged rise in both insulin and glycaemia observed in the hypertonic condition are
evidence of poor glucose tolerance. The data from the HOMA IR, Matsuda, and QUICKI
all agree with one another and indicate compromised insulin sensitivity in the hypertonic
condition. Though these changes are notable, they do not prompt immediate concern
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about an increased risk for diabetes. None of the subjects observed had unusual resting
plasma glucose concentrations, nor did theirs ever surpass 200 mg/dL, the threshold for
diagnosis of diabetes at any random time. Further investigation is necessary to determine
whether long-term reductions in hydration status can lead to symptoms of diabetes or
prediabetes in healthy humans, as was observed by Taveau and colleagues in rats8. The
results of this study only confirm that acute dehydration temporarily impairs glucose
tolerance.
Limitations of this study include the small sample size and restriction to male
subjects. This investigation also did not observe whether similar trends would occur in
children or the elderly. A larger, more broad sample population would give further
insight into the relationship between hydration status and glucose tolerance.
Having confirmed that dehydration impairs glucose tolerance in healthy adults,
we can speculate that there may be implications for the prevention of hyperglycemia and
delay of the onset of diabetes by improving hydration status. This would suggest that a
simple increase in fluid intake of a person at risk for diabetes might be a valid
recommendation to help improve their glucose tolerance, thus reducing their risk of
developing diabetes, as suggested by Taveau and colleagues8. Roussel and colleagues
also suggest increased water intake as a potentially valid means of reducing the risk of
hyperglycemia in healthy adults with nearly no additional cost to the individual or
institution7. Future research should be performed on a wider subject base and over longer
periods of time to determine the importance of the effect hydration status has on glucose
tolerance and the implications for the management and prevention of diabetes.
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